Find the Perfect Plan for Your Investment Journey
S
Latest price
52 Week Range
HK$7.72 - HK$32.00
Next Earnings Date
-
Next Earnings Date
-
Latest price
Market Cap | HK$11.57B |
EV | HK$11.21B |
Shares Outstanding | 479.93M |
Beta | 0.03 |
Analyst Rating | BUY |
Analyst Target Price | HK$16.85 |
P/E 2025E | 20.57x |
P/Revenue 2025E | 4.52x |
Revenue | 15.00% |
EPS | 20.40% |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | 16.40% |
EPS | 15.60% |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | 38.40% |
Net Profit Margin 2025E | 22.22% |
ROE 2025E | 26.59% |
ROCE 2024 | 28.74% |
DPS 2025E | HK$0.27 |
Payout Ratio 2025E | 24.55% |
Div. Yield 2025E | 0.90% |
DPS Last 3Y CAGR | 48.80% |
Price
%
1M
3M
6M
1Y
3Y
5Y
S
Shanghai Conant Optical Co., Ltd.
2276
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Fei, Zhengxiang
Employees
2,723
Website
www.conantoptical.comIPO Date
2021-12-16
Headquarters
Bldg 35, No. 1-42 Ln 83Hongxiang N. Rd, 4th Floor, Lin-gang Special Area China, Pilot Free Trade Zone China, Shanghai China
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved